Escient Pharmaceuticals Competitors and Similar CompaniesClear all

Escient Pharmaceuticals's competitors and similar companies include Confo Therapeutics, Delpor, ALX Oncology and Allakos.

	Escient Pharmaceuticals Escient Pharmaceuticals is a pharmaceutical company that develops therapeutics for neurosensory-inflammatory diseases.	Confo Therapeutics Confo Therapeutics is a drug discovery company based on disruptive technology to enable the discovery of G-protein-coupled receptors (GPCR) agonists.	Delpor Delpor is a life sciences company that utilizes drug delivery technologies to develop therapies for chronic diseases.	ALX Oncology ALX Oncology is a company that develops protein-based therapeutics intended to help in cancer treatment.	Allakos Allakos is a biotechnology company that develops therapeutics targeting allergic, inflammatory, and proliferative diseases.
Founding Date	Founding Date 2018	Founding Date 2015	Founding Date 2009	Founding Date 2015	Founding Date 2012
Type	Type Subsidiary	Type Private	Type Private	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech healthtech pharma therapy	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech life sciences medical devices pharma therapy	Tags Healthcare biotech healthtech oncology pharma therapy	Tags Healthcare biotech pharma therapy
Locations	Locations San Diego, US HQ	Locations Elsene, BE HQ Gent, BE	Locations Brisbane, US HQ	Locations Burlingame, US HQ Dublin 2, IE	Locations San Carlos, US HQ
Employees	Employees 2116% decrease	Employees 761% increase	Employees 9	Employees 743% increase	Employees 6153% decrease
Financial
Net income	Net income N/A	Net income N/A	Net income N/A	Net income ($101.7m) (FY, 2025)	Net income ($115.8m) (FY, 2024)
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 33.5m (about 7 years ago)	Latest funding round $ 1m (about 10 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 117.5m	Total funding raised $ 46m	Total funding raised $ 1.9m	Total funding raised $ 166m	Total funding raised N/A